SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $32,000 | -11.1% | 17,417 | +7.8% | 0.00% | – |
Q4 2017 | $36,000 | -37.9% | 16,153 | +23.7% | 0.00% | – |
Q2 2017 | $58,000 | +5.5% | 13,054 | +10.5% | 0.00% | – |
Q1 2017 | $55,000 | -57.4% | 11,810 | -44.4% | 0.00% | -100.0% |
Q4 2016 | $129,000 | +4.9% | 21,252 | -4.9% | 0.00% | 0.0% |
Q3 2016 | $123,000 | +115.8% | 22,346 | +48.0% | 0.00% | – |
Q2 2016 | $57,000 | -9.5% | 15,097 | -33.7% | 0.00% | -100.0% |
Q1 2016 | $63,000 | -33.0% | 22,760 | +37.7% | 0.00% | 0.0% |
Q4 2015 | $94,000 | +64.9% | 16,531 | +53.0% | 0.00% | 0.0% |
Q3 2015 | $57,000 | – | 10,806 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |